Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MSCI World Ex USA UCITS ETF Dist

WEXF · IE0009BI8Z04 · class UCITS ETF Dist · USD · domicile Ireland
Equity · GlobalSFDR art. 6
Index tracked: MSCI World ex USA Net Total Return USD Index
TER
0.15%+ trans. 0.18%
Fund size
131 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingannual
Launch 12 Feb 2025 · costs from the KID as of 2 Sept 2026 · 741 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of MSCI World ex USA Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund The Index is a net total return index, meaning that dividends net of tax paid by the index constituents are included in the Index return. The MSCI World ex USA Index (the "Index") is a…

Performance since series start (in euro) — base 100

18 Feb 20258 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202612684125
High 126 (13 Aug 2026) · low 84 (7 Apr 2025) · last 125. Past performance is not indicative of future results.

Returns in euro

1 year+23.3%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+25.1%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.05%13.05%
Max drawdown−10.29%−10.29%
Sharpe1.241.24
Sortino1.971.97
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · WEXF · IE0009BI8Z041
RebalixWEXF · IE0009BI8Z04 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: distributing class without a total-return series or distribution history: price alone would understate the fund

Distributions · per share, in USD

Frequency: annual · last 12 months: 0.271 USD (1.94% of NAV) · 7 months of history: not a full year · last ex-date 10 Feb 2026
YearPaymentsTotal (USD)
202610.271

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 741 securities · top-10 weight = 12.2%
Top holdingsWeight
ASML HOLDING NV2.5%
HSBC HOLDINGS PLC1.4%
ROCHE HOLDING AG - GENUSSS CHF1.2%
NOVARTIS AG-REG1.2%
ROYAL BANK OF CANADA1.1%
SHELL PLC GBP1.0%
NESTLE SA-REG1.0%
MITSUBISHI UFJ FINANCIAL GROUP1.0%
ASTRAZENECA GBP1.0%
BHP GROUP LTD1.0%
Countries (% of fund)
Japan21.1%United Kingdom12.6%Canada12.3%France8.5%Switzerland8.2%
Sectors (% of fund)
Financials28.0%Industrials17.6%Information Technology10.1%Health Care9.0%Consumer Discretionary7.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
WEXD · Xetra (Deutsche Börse)
+ 11 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/IE0009BI8Z04/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/IE0009BI8Z04/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/IE0009BI8Z04/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/IE0009BI8Z04
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · WEXF · IE0009BI8Z042